Calgary patient with rare condition ‘first in the world’ to receive experimental gene therapy

Doctors in Calgary have used gene therapy, in what is believed to be a world-first, to treat a patient with a rare condition that can damage major organs.

The man has Fabry disease, which is a rare, inherited enzyme deficiency that is known to effect more than 400 Canadians.  It results in a build-up of fat known as Gb3 and can lead to problems with the kidneys, heart and brain.

Read the full article...